News Hongchang International Co., Ltd

Equities

HCIL

US42831T2024

Market Closed - OTC Markets Other stock markets 09:31:03 2024-05-06 EDT			5-day change	1st Jan Change
0.2501 ^USD	+12.35%		+12.35%	-28.30%

04-01	Hongchang International Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI
04-01	Hongchang International Co., Ltd Announces Board Changes	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hongchang International Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	04-01	CI
Hongchang International Co., Ltd Announces Board Changes	04-01	CI
Hongchang International Co., Ltd. has Changed its Ticker to HCIL from HYBT	11-28	CI
Heyu Biological Technology Corporation has Changed its Name to Hongchang International Co., Ltd	11-21	CI
Hongchang International Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Hong Chang Biotechnologies (HK) Limited completed the acquisition of Heyu Biological Technology Corporation (OTCPK:HYBT.D) in a reverse merger transaction.	23-09-03	CI
Heyu Biological Technology Corporation Appoints Zengqiang Lin as the Chief Executive Officer	23-08-23	CI
Heyu Biological Technology Corporation Announces Board and Executive Changes	23-08-23	CI
Heyu Biological Technology Corporation Appoints Wendy Wei Li as the Chief Financial Officer of the Company	23-08-23	CI
Hong Chang Biotechnologies (HK) Limited entered into an agreement to acquire Heyu Biological Technology Corporation (OTCPK:HYBT.D) in a reverse merger transaction for HKD 4.4 billion.	23-08-22	CI
Heyu Biological Technology Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-16	CI
Insider Buy: Heyu Biological Technology	23-05-31	MT
Heyu Biological Technology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
HEYU BIOLOGICAL TECHNOLOGY CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-03-23	AQ
Heyu Biological Technology Corporation Auditor Raises 'Going Concern' Doubt	23-03-22	CI
HEYU BIOLOGICAL TECHNOLOGY : ANNOUNCES APPOINTMENT OF NEW INDEPENDENT DIRECTOR - Form 8-K	23-02-22	PU
HEYU BIOLOGICAL TECHNOLOGY CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-02-22	AQ
Heyu Biological Technology Corporation Appoints Zengqiang Lin as an Independent Director of the Company	23-02-22	CI
HEYU BIOLOGICAL TECHNOLOGY CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	23-02-13	AQ
Heyu Biological Technology Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	23-02-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hongchang International Co., Ltd

Equities

HCIL

US42831T2024

Summary

Filters